LNAI
Lunai Bioworks Inc. NASDAQ Listed Sep 30, 2025$3.09
-5.50%
vs $3.27
Mkt Cap $51.0M
52w Low $0.18
70.6% of range
52w High $4.30
50d MA $1.89
200d MA $1.14
P/E (TTM)
-0.1x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.5x
ROE
1273.6%
P/FCF
-6.5x
RSI (14)
59.60
ATR (14)
$0.65
Beta
0.49
50d MA
$1.89
200d MA
$1.14
Avg Volume
1.7M
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
2080 Century Park East · Los Angeles, CA 90067 · US
Data updated apr 25, 2026 7:28pm
· Source: financialmodelingprep.com